Pacific Biosciences of California, Inc. (PACB)
USD 1.19
(-6.3%)
USD 1.19
(-6.3%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 392.66 Million USD | -0.89% |
| 2022 | 353.85 Million USD | 49.29% |
| 2021 | 237.02 Million USD | 73.07% |
| 2020 | 136.95 Million USD | 1.35% |
| 2019 | 135.12 Million USD | 7.17% |
| 2018 | 126.08 Million USD | 1.32% |
| 2017 | 124.44 Million USD | 7.83% |
| 2016 | 115.4 Million USD | 9.26% |
| 2015 | 105.62 Million USD | 22.46% |
| 2014 | 86.25 Million USD | 2.73% |
| 2013 | 83.96 Million USD | -11.88% |
| 2012 | 95.27 Million USD | -22.41% |
| 2011 | 122.79 Million USD | -13.47% |
| 2010 | 141.9 Million USD | 60.88% |
| 2009 | 88.2 Million USD | 92.97% |
| 2008 | 45.71 Million USD | 78.88% |
| 2007 | 25.55 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 85.86 Million USD | -11.84% |
| 2024 Q2 | 68.3 Million USD | -20.45% |
| 2023 Q2 | 86.74 Million USD | -2.27% |
| 2023 Q1 | 88.75 Million USD | 1.29% |
| 2023 Q4 | 97.38 Million USD | 6.22% |
| 2023 Q3 | 91.68 Million USD | 5.69% |
| 2023 FY | 350.71 Million USD | -0.89% |
| 2022 Q3 | 83.88 Million USD | -6.38% |
| 2022 Q2 | 89.6 Million USD | -3.39% |
| 2022 Q4 | 87.62 Million USD | 4.46% |
| 2022 FY | 353.85 Million USD | 49.29% |
| 2022 Q1 | 92.74 Million USD | 16.08% |
| 2021 FY | 237.02 Million USD | 73.07% |
| 2021 Q1 | 46.68 Million USD | 31.97% |
| 2021 Q2 | 51.32 Million USD | 9.94% |
| 2021 Q3 | 59.11 Million USD | 15.17% |
| 2021 Q4 | 79.89 Million USD | 35.16% |
| 2020 Q3 | 31.23 Million USD | 3.66% |
| 2020 Q2 | 30.13 Million USD | -25.03% |
| 2020 Q1 | 40.19 Million USD | 30.3% |
| 2020 FY | 136.95 Million USD | 1.35% |
| 2020 Q4 | 35.37 Million USD | 13.25% |
| 2019 FY | 135.12 Million USD | 7.17% |
| 2019 Q1 | 35.25 Million USD | -3.07% |
| 2019 Q2 | 33.99 Million USD | -3.57% |
| 2019 Q3 | 35.02 Million USD | 3.04% |
| 2019 Q4 | 30.84 Million USD | -11.93% |
| 2018 Q3 | 27.86 Million USD | -8.97% |
| 2018 Q1 | 31.24 Million USD | 4.07% |
| 2018 FY | 126.08 Million USD | 1.32% |
| 2018 Q4 | 36.36 Million USD | 30.53% |
| 2018 Q2 | 30.6 Million USD | -2.04% |
| 2017 Q1 | 32.23 Million USD | 10.22% |
| 2017 FY | 124.44 Million USD | 7.83% |
| 2017 Q4 | 30.02 Million USD | 0.76% |
| 2017 Q3 | 29.79 Million USD | -8.0% |
| 2017 Q2 | 32.38 Million USD | 0.47% |
| 2016 Q2 | 28.71 Million USD | 2.3% |
| 2016 Q3 | 29.37 Million USD | 2.3% |
| 2016 Q4 | 29.24 Million USD | -0.43% |
| 2016 FY | 115.4 Million USD | 9.26% |
| 2016 Q1 | 28.06 Million USD | 1.97% |
| 2015 Q4 | 27.52 Million USD | 2.03% |
| 2015 Q1 | 25.25 Million USD | 13.09% |
| 2015 Q2 | 25.86 Million USD | 2.41% |
| 2015 Q3 | 26.98 Million USD | 4.31% |
| 2015 FY | 105.62 Million USD | 22.46% |
| 2014 Q3 | 21.57 Million USD | 0.69% |
| 2014 Q1 | 20.92 Million USD | 3.61% |
| 2014 FY | 86.25 Million USD | 2.73% |
| 2014 Q4 | 22.33 Million USD | 3.51% |
| 2014 Q2 | 21.42 Million USD | 2.42% |
| 2013 Q4 | 20.19 Million USD | -4.64% |
| 2013 Q3 | 21.17 Million USD | 0.57% |
| 2013 Q2 | 21.05 Million USD | -2.23% |
| 2013 Q1 | 21.53 Million USD | -3.51% |
| 2013 FY | 83.96 Million USD | -11.88% |
| 2012 Q1 | 27.35 Million USD | 12.93% |
| 2012 Q2 | 22.83 Million USD | -16.55% |
| 2012 Q4 | 22.32 Million USD | -1.97% |
| 2012 Q3 | 22.76 Million USD | -0.27% |
| 2012 FY | 95.27 Million USD | -22.41% |
| 2011 Q2 | 30.56 Million USD | -13.27% |
| 2011 Q1 | 35.23 Million USD | -4.43% |
| 2011 FY | 122.79 Million USD | -13.47% |
| 2011 Q4 | 24.22 Million USD | -26.06% |
| 2011 Q3 | 32.76 Million USD | 7.21% |
| 2010 Q3 | 40.91 Million USD | 22.86% |
| 2010 Q4 | 36.86 Million USD | -9.89% |
| 2010 Q1 | 30.81 Million USD | 9.25% |
| 2010 FY | 141.9 Million USD | 60.88% |
| 2010 Q2 | 33.3 Million USD | 8.06% |
| 2009 Q4 | 28.2 Million USD | 14.82% |
| 2009 FY | 88.2 Million USD | 92.97% |
| 2009 Q3 | 24.56 Million USD | 0.0% |
| 2008 FY | 45.71 Million USD | 78.88% |
| 2007 FY | 25.55 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -3398.45% |
| Cerus Corporation | 143.15 Million USD | -174.294% |
| OrthoPediatrics Corp. | 137.01 Million USD | -186.578% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -3356.303% |
| Talis Biomedical Corporation | 67.18 Million USD | -484.446% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -1474.064% |
| Inogen, Inc. | 236.08 Million USD | -66.324% |
| Spectral AI, Inc. | 20.86 Million USD | -1782.026% |
| Nano-X Imaging Ltd. | 55.99 Million USD | -601.227% |
| CVRx, Inc. | 76.14 Million USD | -415.702% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -11030.001% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -3044.095% |
| Orthofix Medical Inc. | 667.42 Million USD | 41.167% |
| Venus Concept Inc. | 80.47 Million USD | -387.929% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | -594.026% |
| Bioventus Inc. | 409.91 Million USD | 4.209% |
| BrainsWay Ltd. | 28.01 Million USD | -1301.478% |
| Envoy Medical, Inc. | 17.89 Million USD | -2093.91% |
| electroCore, Inc. | 32.03 Million USD | -1125.894% |
| IceCure Medical Ltd | 16.87 Million USD | -2226.772% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -825.401% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -2126.878% |
| MaxCyte, Inc. | 84.84 Million USD | -362.804% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -3063.659% |
| Nexalin Technology, Inc. | 5.78 Million USD | -6691.936% |
| PAVmed Inc | 64.82 Million USD | -505.714% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -668.758% |
| RxSight, Inc. | 103.85 Million USD | -278.109% |
| Sight Sciences, Inc. | 126.44 Million USD | -210.533% |
| SI-BONE, Inc. | 156.35 Million USD | -151.144% |
| TELA Bio, Inc. | 84.18 Million USD | -366.421% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | -460.503% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | -93.084% |
| LivaNova PLC | 843.54 Million USD | 53.451% |
| 908 Devices Inc. | 68.08 Million USD | -476.771% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 18.803% |
| Nemaura Medical Inc. | 7.13 Million USD | -5400.446% |
| NeuroPace, Inc. | 75.29 Million USD | -421.496% |
| LENSAR, Inc. | 33.33 Million USD | -1077.904% |
| Apyx Medical Corporation | 51.01 Million USD | -669.662% |
| Cutera, Inc. | 197.72 Million USD | -98.593% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -1484.545% |
| BioSig Technologies, Inc. | 28.53 Million USD | -1276.327% |
| Anika Therapeutics, Inc. | 191.47 Million USD | -105.074% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -988.924% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 53.052% |
| Axonics, Inc. | 270.2 Million USD | -45.323% |
| Outset Medical, Inc. | 198.77 Million USD | -97.548% |
| IRIDEX Corporation | 31.81 Million USD | -1134.255% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | -117.883% |
| IRadimed Corporation | 30.12 Million USD | -1203.55% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -4502.274% |
| INVO Bioscience, Inc. | 7.85 Million USD | -4900.017% |
| Telesis Bio, Inc. | 63.48 Million USD | -518.479% |
| Viemed Healthcare, Inc. | 98.45 Million USD | -298.836% |
| Varex Imaging Corporation | 224.8 Million USD | -74.673% |
| Quipt Home Medical Corp. | 148.66 Million USD | -164.125% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -3249.535% |
| Pulmonx Corporation | 112.68 Million USD | -248.457% |
| Dynatronics Corporation | 9.9 Million USD | -3863.11% |
| Modular Medical, Inc. | 17.52 Million USD | -2140.094% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -1845.143% |
| Semler Scientific, Inc. | 38.94 Million USD | -908.284% |
| InMode Ltd. | 215.68 Million USD | -82.06% |
| Bruker Corporation | 1.07 Billion USD | 63.52% |
| Cytosorbents Corporation | 48.33 Million USD | -712.353% |
| DexCom, Inc. | 1.69 Billion USD | 76.782% |
| Align Technology, Inc. | 2.07 Billion USD | 81.093% |
| Viveve Medical, Inc. | 22.17 Million USD | -1670.92% |
| ZimVie Inc. | 275.12 Million USD | -42.722% |
| Movano Inc. | 29.69 Million USD | -1222.553% |
| Cytek Biosciences, Inc. | 137.27 Million USD | -186.052% |
| Nexalin Technology, Inc. | 5.78 Million USD | -6691.936% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -11030.001% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 34.656% |
| Profound Medical Corp. | 33.6 Million USD | -1068.539% |
| Insulet Corporation | 939.9 Million USD | 58.223% |
| enVVeno Medical Corporation | 25.23 Million USD | -1455.852% |
| Surmodics, Inc. | 98.69 Million USD | -297.85% |
| iCAD, Inc. | 22.22 Million USD | -1666.776% |
| Nuwellis, Inc. | 22.61 Million USD | -1636.461% |
| Biotricity, Inc. | 17.18 Million USD | -2184.994% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 11.936% |
| Aethlon Medical, Inc. | 12.27 Million USD | -3098.254% |
| InspireMD, Inc. | 22.95 Million USD | -1610.963% |
| PAVmed Inc. | 64.82 Million USD | -505.714% |
| BIOLASE, Inc. | 34.66 Million USD | -1032.876% |
| Beyond Air, Inc. | 61.7 Million USD | -536.412% |
| FONAR Corporation | 28.6 Million USD | -1272.733% |
| AxoGen, Inc. | 149.33 Million USD | -162.941% |
| Vivani Medical, Inc. | 26.96 Million USD | -1356.206% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | -121.73% |
| Inari Medical, Inc. | 448.59 Million USD | 12.468% |
| UFP Technologies, Inc. | 58.08 Million USD | -575.973% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -7868.708% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -6114.752% |
| Tenon Medical, Inc. | 16.96 Million USD | -2214.156% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -5211.322% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -790.342% |
| AdaptHealth Corp. | 1.07 Billion USD | 63.573% |
| Sintx Technologies, Inc. | 15.2 Million USD | -2483.159% |
| NanoVibronix, Inc. | 4.97 Million USD | -7795.958% |
| Quanterix Corporation | 118.1 Million USD | -232.486% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -3249.535% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -2618.917% |
| TransMedics Group, Inc. | 182.82 Million USD | -114.783% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -1299.131% |
| NeuroMetrix, Inc. | 11.09 Million USD | -3437.871% |
| Hyperfine, Inc. | 52.87 Million USD | -642.673% |
| Establishment Labs Holdings Inc. | 172 Million USD | -128.29% |
| Biomerica, Inc. | 6.97 Million USD | -5527.2% |
| Bone Biologics Corporation | 9.42 Million USD | -4064.758% |
| AVITA Medical, Inc. | 80.77 Million USD | -386.098% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -3708.144% |
| Silk Road Medical, Inc | 186.35 Million USD | -110.706% |